Crossref
journal-article
Elsevier BV
Trends in Neurosciences (78)
References
79
Referenced
413
- de Rijk, M.C. et al. (2000) Prevalence of Parkinson's disease in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 54 (11, Suppl. 5), S21–S23
10.1111/j.1749-6632.2003.tb07458.x
/ Ann. N. Y. Acad. Sci. / Description of Parkinson's disease as a clinical syndrome by Fahn (2003)10.1146/annurev.biochem.74.082803.133400
/ Annu. Rev. Biochem. / The biochemistry of Parkinson's disease by Cookson (2005)10.1146/annurev.neuro.28.061604.135718
/ Annu. Rev. Neurosci. / Molecular pathophysiology of Parkinson's disease by Moore (2005)10.1016/j.neuron.2004.10.023
/ Neuron / Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease by Paisan-Ruiz (2004)10.1016/j.neuron.2004.11.005
/ Neuron / Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology by Zimprich (2004)10.1002/ana.20456
/ Ann. Neurol. / Clinical features of LRRK2-associated Parkinson's disease in central Norway by Aasly (2005)10.1093/brain/awh666
/ Brain / Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson's disease by Berg (2005)10.1093/brain/awh667
/ Brain / Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data by Khan (2005)10.1007/s10048-005-0005-1
/ Neurogenetics / Lrrk2 pathogenic substitutions in Parkinson's disease by Mata (2005)10.1212/01.WNL.0000169023.51764.b0
/ Neurology / LRRK2 mutations in Parkinson disease by Farrer (2005)10.1212/01.WNL.0000172630.22804.73
/ Neurology / A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations by Zabetian (2005)10.1056/NEJMc055540
/ N. Engl. J. Med. / LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs by Lesage (2006)10.1086/432422
/ Am. J. Hum. Genet. / LRRK2 haplotype analyses in European and North African families with Parkinson disease: a common founder for the G mutation dating from the 13th century by Lesage (2005)10.1056/NEJMc055509
/ N. Engl. J. Med. / LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews by Ozelius (2006)10.1016/S0140-6736(05)17829-5
/ Lancet / A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease by Di Fonzo (2005)10.1086/429256
/ Am. J. Hum. Genet. / Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations by Kachergus (2005){'key': '10.1016/j.tins.2006.03.006_bib18', 'first-page': '410', 'article-title': "Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease", 'volume': '365', 'author': 'Nichols', 'year': '2005', 'journal-title': 'Lancet'}
/ Lancet / Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease by Nichols (2005){'key': '10.1016/j.tins.2006.03.006_bib19', 'first-page': '415', 'article-title': "A common LRRK2 mutation in idiopathic Parkinson's disease", 'volume': '365', 'author': 'Gilks', 'year': '2005', 'journal-title': 'Lancet'}
/ Lancet / A common LRRK2 mutation in idiopathic Parkinson's disease by Gilks (2005)10.1002/ana.20731
/ Ann. Neurol. / Lrrk2 and Lewy body disease by Ross (2006)10.1016/S1353-8020(97)00013-8
/ Parkinsonism Relat. Disord. / German–Canadian family (Family A) with parkinsonism, amyotrophy, and dementia – longitudinal observations by Wszolek (1997)10.1016/j.molmed.2005.12.004
/ Trends Mol. Med. / LRRK2: a common pathway for parkinsonism, pathogenesis and prevention? by Taylor (2006)10.1016/j.neuroscience.2006.01.017
/ Neuroscience / Anatomical localization of leucine-rich repeat kinase 2 in mouse brain by Melrose (2006)10.1111/j.1460-9568.2006.04616.x
/ Eur. J. Neurosci. / LRRK2 is expressed in areas affected by Parkinson's disease in the adult mouse brain by Simon-Sanchez (2006)10.1016/j.cellsig.2005.08.015
/ Cell. Signal. / LRRK1 protein kinase activity is stimulated upon binding of GTP to its Roc domain by Korr (2006)10.1016/j.bbamcr.2003.08.008
/ Biochim. Biophys. Acta / Roc, a Ras/GTPase domain in complex proteins by Bosgraaf (2003)10.1126/science.1075762
/ Science / The protein kinase complement of the human genome by Manning (2002)10.1006/jsbi.2001.4392
/ J. Struct. Biol. / Protein repeats: structures, functions, and evolution by Andrade (2001)10.1016/S0092-8674(00)80351-7
/ Cell / Activation mechanism of the MAP kinase ERK2 by dual phosphorylation by Canagarajah (1997)10.1016/S0092-8674(02)00741-9
/ Cell / The conformational plasticity of protein kinases by Huse (2002)10.1016/j.molcel.2004.08.024
/ Mol. Cell / Regulation of protein kinases; controlling activity through activation segment conformation by Nolen (2004)10.1016/S0140-6736(05)74809-1
/ Lancet / LRRK2 mutations and Parkinsonism by Toft (2005)10.1016/S0140-6736(05)74810-8
/ Lancet / LRRK2 mutations and Parkinsonism by Albrecht (2005)10.1016/j.parkreldis.2005.09.003
/ Parkinsonism Relat. Disord. / The LRRK2 I2012T, G2019S, and I2020T mutations are rare in Taiwanese patients with sporadic Parkinson's disease by Lu (2005)10.1073/pnas.0507360102
/ Proc. Natl. Acad. Sci. U. S. A. / Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity by West (2005)10.1093/hmg/ddi439
/ Hum. Mol. Genet. / The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity by Gloeckner (2006)10.1016/j.tibs.2005.01.003
/ Trends Biochem. Sci. / The RIP kinases: crucial integrators of cellular stress by Meylan (2005)10.1016/j.cbpa.2005.04.004
/ Curr. Opin. Chem. Biol. / MAPK kinase kinases (MKKKs) as a target class for small-molecule inhibition to modulate signaling networks and gene expression by Johnson (2005)10.1126/science.1072682
/ Science / Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases by Johnson (2002)10.1002/j.1460-2075.1996.tb01007.x
/ EMBO J. / RIP mediates tumor necrosis factor receptor 1 activation of NF-κB but not Fas/APO-1-initiated apoptosis by Ting (1996)10.1038/nrm1498
/ Nat. Rev. Mol. Cell Biol. / The RAF proteins take centre stage by Wellbrock (2004)10.1038/nrm906
/ Nat. Rev. Mol. Cell Biol. / Mixed-lineage kinase control of JNK and p38 MAPK pathways by Gallo (2002)10.1146/annurev.pharmtox.44.101802.121840
/ Annu. Rev. Pharmacol. Toxicol. / Mixed-lineage kinases: a target for the prevention of neurodegeneration by Wang (2004)10.1016/S0003-9861(02)00244-8
/ Arch. Biochem. Biophys. / Untying the regulation of the Raf-1 kinase by Dhillon (2002)10.1074/jbc.M103496200
/ J. Biol. Chem. / Function of the Rho family GTPases in Ras-stimulated Raf activation by Li (2001)10.1074/jbc.M502671200
/ J. Biol. Chem. / Cdc42 induces activation loop phosphorylation and membrane targeting of mixed lineage kinase 3 by Du (2005)10.1074/jbc.273.49.32408
/ J. Biol. Chem. / Dimerization via tandem leucine zippers is essential for the activation of the mitogen-activated protein kinase kinase kinase, MLK-3 by Leung (1998)10.1074/jbc.M002858200
/ J. Biol. Chem. / Zipper-mediated oligomerization of the mixed lineage kinase SPRK/MLK-3 is not required for its activation by the GTPase cdc42 but is necessary for its activation of the JNK pathway by Vacratsis (2000)-
Stenmark, H. and Olkkonen, V.M. (2001) The Rab GTPase family. Genome Biol. 2reviews3007.1–reviews3007.7
(
10.1186/gb-2001-2-5-reviews3007
) 10.1016/S0962-8924(00)01740-2
/ Trends Cell Biol. / Understanding Ras: ‘it ain't over ‘til it's over’ by Shields (2000)10.1146/annurev.cellbio.21.020604.150721
/ Annu. Rev. Cell Dev. Biol. / Rho GTPases: biochemistry and biology by Jaffe (2005)10.1242/jcs.01582
/ J. Cell Sci. / Rho signalling at a glance by Schwartz (2004)10.1073/pnas.0508052102
/ Proc. Natl. Acad. Sci. U. S. A. / Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration by Smith (2005)10.1042/EB0410015
/ Essays Biochem. / E3 ubiquitin ligases by Ardley (2005)10.1038/33416
/ Nature / Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism by Kitada (1998)10.1016/j.bbamcr.2004.09.026
/ Biochim. Biophys. Acta / Ubiquitin, proteasome and parkin by Tanaka (2004)10.1126/science.285.5428.751
/ Science / Detecting protein function and protein–protein interactions from genome sequences by Marcotte (1999)10.1110/ps.03554604
/ Protein Sci. / The ankyrin repeat as molecular architecture for protein recognition by Mosavi (2004)10.1038/sj.onc.1202918
/ Oncogene / Functional evaluation of tumour-specific variants of p16INK4a/CDKN2A: correlation with protein structure information by Ruas (1999)10.1038/26155
/ Nature / Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a by Russo (1998)10.1038/383707a0
/ Nature / Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia by Joutel (1996)10.1110/ps.03279003
/ Protein Sci. / Structure and stability of the ankyrin domain of the Drosophila Notch receptor by Zweifel (2003)10.1016/S0959-440X(01)00266-4
/ Curr. Opin. Struct. Biol. / The leucine-rich repeat as a protein recognition motif by Kobe (2001)10.1212/01.wnl.0000180517.70572.37
/ Neurology / Analysis of LRRK2 functional domains in nondominant Parkinson disease by Skipper (2005)10.1110/ps.9.12.2470
/ Protein Sci. / Thirty-plus functional families from a single motif by Yu (2000)10.1038/35107009
/ Nature / Multisite phosphorylation of a CDK inhibitor sets a threshold for the onset of DNA replication by Nash (2001)10.1146/annurev.biophys.33.110502.133346
/ Annu. Rev. Biophys. Biomol. Struct. / The use of in vitro peptide-library screens in the analysis of phosphoserine/threonine-binding domain structure and function by Yaffe (2004)10.1016/j.yjmcc.2004.04.019
/ J. Mol. Cell. Cardiol. / Interaction of Gβγ with RACK1 and other WD40 repeat proteins by Chen (2004)10.1016/S0022-2836(03)00514-X
/ J. Mol. Biol. / Structural fingerprints of the Ras-GTPase activating proteins neurofibromin and p120GAP by Ahmadian (2003)10.1016/S0968-0004(99)01429-2
/ Trends Biochem. Sci. / GEFs: structural basis for their activation of small GTP-binding proteins by Cherfils (1999)10.1212/01.WNL.0000167552.79769.b3
/ Neurology / LRRK2 gene in Parkinson disease by Paisan-Ruiz (2005)10.1016/j.neulet.2005.03.033
/ Neurosci. Lett. / LRRK2 R1441G in Spanish patients with Parkinson's disease by Mata (2005){'key': '10.1016/j.tins.2006.03.006_bib73', 'article-title': "Parkinson's disease and LRRK2: Frequency of a common mutation in U.S. movement disorder clinics", 'author': 'Kay', 'year': '2005', 'journal-title': 'Mov Disord.'}
/ Mov Disord. / Parkinson's disease and LRRK2: Frequency of a common mutation in U.S. movement disorder clinics by Kay (2005)10.1002/ana.20484
/ Ann. Neurol. / An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family by Funayama (2005)10.1002/mds.20618
/ Mov. Disord. / Escaping Parkinson's disease: a neurologically healthy octogenarian with the LRRK2 G2019S mutation by Kay (2005)10.1093/bioinformatics/btg124
/ Bioinformatics / 3D-Jury: a simple approach to improve protein structure predictions by Ginalski (2003)10.1093/nar/25.17.3389
/ Nucleic Acids Res. / Gapped BLAST and PSI-BLAST: a new generation of protein database search programs by Altschul (1997)10.1093/nar/gki418
/ Nucleic Acids Res. / FFAS03: a server for profile-profile sequence alignments by Jaroszewski (2005)10.1016/0263-7855(96)00009-4
/ J. Mol. Graph. / MOLMOL: a program for display and analysis of macromolecular structures by Koradi (1996)
Dates
Type | When |
---|---|
Created | 19 years, 4 months ago (April 18, 2006, 3:18 p.m.) |
Deposited | 4 years, 1 month ago (July 25, 2021, 2:45 p.m.) |
Indexed | 1 week, 2 days ago (Aug. 27, 2025, 11:58 a.m.) |
Issued | 19 years, 4 months ago (May 1, 2006) |
Published | 19 years, 4 months ago (May 1, 2006) |
Published Print | 19 years, 4 months ago (May 1, 2006) |
@article{Mata_2006, title={LRRK2 in Parkinson’s disease: protein domains and functional insights}, volume={29}, ISSN={0166-2236}, url={http://dx.doi.org/10.1016/j.tins.2006.03.006}, DOI={10.1016/j.tins.2006.03.006}, number={5}, journal={Trends in Neurosciences}, publisher={Elsevier BV}, author={Mata, Ignacio F. and Wedemeyer, William J. and Farrer, Matthew J. and Taylor, Julie P. and Gallo, Kathleen A.}, year={2006}, month=may, pages={286–293} }